The invention relates to adenosine A3 receptor modulators of formula (I) and to a method for preparing said compounds. Other aspects of the present invention are pharmaceutical compositions comprising an effective quantity of said compounds and the use of the compounds in the preparation of a drug for treating pathological disorders or diseases that can be improves by adenosine A3 receptor modulation.